The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Negative Impact of New-Onset Diabetes Mellitus on Patient and Graft Survival After Liver Transplantation: Long-Term Follow Up
Abstract
BACKGROUND: Little is known about the long-term consequences of new-onset diabetes mellitus (NODM) after liver transplantation (LTX). METHODS: In a chart review between 1996 and 2004, we evaluated its incidence and possible effect on patient and graft survival. Inclusion criteria were: adult primary LTX; deceased donor LTX without combined organs; and dual immunosuppression with tacrolimus and corticosteroid. Patients who died within six months after LTX were excluded. For analytical purposes, each patient was classified into one of four groups: 1) preLTX diabetes mellitus (DM): established DM before LTX; 2) sustained NODM: NODM sustained > or =6 months; 3) transitory NODM: NODM temporarily existed > or =1 and <6 months; and 4) normal: no DM either pre- or postLTX. Patients who had NODM <1 month due to high-dose steroid (e.g., either immediate postLTX or rejection treatment) were considered as normal. Patient and graft survival was examined using Kaplan-Meier methodology. RESULTS: In all, 778 patients met the inclusion/exclusion criteria: preLTX DM 159 (20.4%), sustained NODM 284 (36.5%), transitory NODM 108 (13.9%), and normal 227 (29.2%). Median follow-up was 57.2 months. There was a significant difference in patient (P = 0.012) and graft survival (P = 0.004) among the groups, with sustained NODM showing the poorest patient and graft survivals. Sustained NODM patients had a significantly higher rate of death due to infection, as well as graft failure due to chronic rejection and late onset hepatic artery thrombosis. CONCLUSION: NODM is a frequent complication with poor patient and graft survival after LTX.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heisel, O., Heisel, R., Balshaw, R., & Keown, P. (2004) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00372.x · Cited by 506
Cited by
Watt, K. D. S., Pedersen, R. A., Kremers, W. K., Heimbach, J. K., & Charlton, M. R. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03126.x · Cited by 785
Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes
Shivaswamy, V., Boerner, B., & Larsen, J. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1084 · Cited by 328
Post-transplant obesity impacts long-term survival after liver transplantation
van Son, J., Stam, S. P., Gomes-Neto, A. W., Osté, M. C. J., Blokzijl, H., van den Berg, A. P., Porte, R. J., Bakker, S. J. L., & de Meijer, V. E. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154204 · Cited by 70
Chen, T., Jia, H., Li, J., Chen, X., Zhou, H., & Tian, H. (2009) · Transplant International · doi:10.1111/j.1432-2277.2008.00804.x · Cited by 68
Management of metabolic syndrome and cardiovascular risk after liver transplantation
Fatourou, E. M., & Tsochatzis, E. A. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30181-5 · Cited by 59
Metadata
- Authors
- Moon, J. I., Barbeito, R., Faradji, R. N., Gaynor, J. J., & Tzakis, A. G.
- Venue
- Transplantation
- Published
- 2006-12-27
- Volume
- 82
- Issue
- 12
- Pages
- 1625-1628
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W2044150525
- Cited by
- 189
- References
- 1
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Negative Impact of New-Onset Diabetes Mellitus on Patient and Graft Survival After Liver Transplantation: Long-Term Follow Up. https://app.cochat.ai/papers/10.1097/01.tp.0000250361.60415.96
- The paper
- Moon, J. I., Barbeito, R., Faradji, R. N., Gaynor, J. J., & Tzakis, A. G. (2006). Negative Impact of New-Onset Diabetes Mellitus on Patient and Graft Survival After Liver Transplantation: Long-Term Follow Up. Transplantation. https://doi.org/10.1097/01.tp.0000250361.60415.96
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.